Business Context and Reporting Period
This Form 6-K filing by Fresenius Medical Care AG & Co. KGaA covers the month of April 2019. The report details the filing of an updated base prospectus with the Commission de Surveillance du Secteur Financier (CSSF) for the Company's €10 billion European Medium-Term Note Program. The filing includes audited consolidated financial statements for Fresenius Medical Care Holdings, Inc. (FMCH) and its subsidiaries for the years ended December 31, 2018, and 2017, submitted to comply with Luxembourg law and SEC Rule 13a-16.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. While the document references the inclusion of audited consolidated financial statements for FMCH for the years ended December 31, 2018, and 2017 as Exhibit 99.1, the actual financial data tables and figures are not contained within the provided text.
Material Changes
The filing does not disclose material changes in financial performance or operations compared to prior periods. The primary activity reported is the administrative update of the base prospectus for the €10 billion note program and the subsequent public availability of historical financial statements via the Luxembourg Stock Exchange and the Company's website.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, or specific risk factors are not included in this filing text. The document notes a regulatory restriction: notes issued under the Program may not be offered or sold in the United States absent registration under the US Securities Act of 1933 or an applicable exemption. Furthermore, notes will not be offered to "US persons" as defined in Regulation S.
Investor Verification Checklist
- Verify the specific financial figures for FMCH by reviewing Exhibit 99.1 (Audited consolidated financial statements for 2018 and 2017), as these are referenced but not detailed in the filing text.
- Confirm the status of the €10 billion European Medium-Term Note Program and any subsequent issuances.
- Review the Luxembourg Stock Exchange website for the public posting of the referenced audited statements.
- Assess the impact of the US offering restrictions on potential investor eligibility for notes under this program.